John Mascarenhas, MD Associate Professor of Medicine, Myeloproliferative Disorders Program-Division of Hematology/Oncology @IcahnMountSinai tells us about his approach to the individualized management of myeloproliferative neoplasms.
[the_ad id="32629"]